Loading clinical trials...
Loading clinical trials...
A Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3540378 in Healthy Participants
Conditions
Interventions
LY3540378
Placebo
+1 more
Locations
2
United States
Anaheim Clinical Trials, LLC
Anaheim, California, United States
Lilly Centre for Clinical Pharmacology
Singapore, Singapore
Start Date
March 17, 2021
Primary Completion Date
May 30, 2022
Completion Date
May 30, 2022
Last Updated
June 21, 2022
NCT00104325
NCT07388667
NCT05447416
NCT03878121
NCT01399385
NCT07090785
Lead Sponsor
Eli Lilly and Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions